An oral antibiotic, called zoliflodacin, was shown to be effective against the bacterium that causes the sexually transmitted disease gonorrhoea.
These two latest achievements suggest that non-profits could help to solve the problem of drug access, while fending off the rise of drug-resistance.
[
add
]
[
|
|
...
]